Effect of dicarboxymethyl trisodium alginate on the expression of BMP-7 protein in bone tissues of rats with traumatic femoral neck fracture

DOI: 10.18805/ijar.v0i0f.3802    | Article Id: B-552 | Page : 474-477
Citation :- Effect of dicarboxymethyl trisodium alginate on the expression of BMP-7 protein in bone tissues of rats with traumatic femoral neck fracture .Indian Journal Of Animal Research.2017.(51):474-477

Zhao Qin* and LiPing Guan

Address :

Department of Function Science Lab, Xinxiang Medical College, 453003 Xinxiang, China.

Submitted Date : 7-06-2016
Accepted Date : 10-08-2016


Bone morphogenetic protein-7 (BMP-7) is a pivotal skeletal growth factor. Sodium alginate (SA) is a natural polysaccharide polymer extracted from brown alga. Partial uronic acid units of sodium alginate can be transformed into aldehyde groups, namely dicarboxymethyl trisodium alginate (DCMTSA). In this investigation, rats with traumatic femoral neck fractures were selected. The rats treated with dicarboxymethyl trisodium alginate intervention were assigned to the experimental group, those treated with sodium alginate intervention were in the control group, and those receiving no medical intervention were in the placebo group. The expression of BMP-7 at both the protein and mRNA levels in the rat fracture tissues in all three groups was quantitatively detected by immunohistochemicals SP and RT-PCR. Results revealed that both dicarboxymethyl trisodium alginate and sodium alginate induced the up-regulation of BMP-7 expression. However, the effect of dicarboxymethyl trisodium alginate was superior to that of sodium alginate. Therefore, dicarboxymethyl trisodium alginate can be used to promote the release of BMP-7 from bone cells and contribute to the bone union in traumatic femoral neck fracture in rat models. 


BMP-7 Dicarboxymethyl trisodium alginate Traumatic femoral neck fracture.


  1. Atsuki Yamamoto, Tomokazu Itoh, Reishi Nasu, et al. (2014) Sodium alginate ameli-orates indomethacin-induced gastrointestinal mucosal injury via inhibiting translocation in rats. World Journal of Gastroenterology, 14;20:2641-2652
  2. Corinaldesi G, Piersanti L, Piattelli A, et al.(2013)Augmentation of the floor of the maxillary sinus with recombinant human bone morphogenetic protein-7: a pilot radiological and histological study in humans. British Journal of Oral & Maxillofacial Surgery. 51:247-252
  3. Flor M. Pérez-Campo, Ana Santurtún, Carmen García-Ibarbia, et al. (2016.) Osterix and RUNX2 are Transcriptional Regulators of Sclerostin in Human Bone. Calcified Tissue International, 1-8.
  4. Jin P, Yoshioka Y, Mandai M, et al.(2015)The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer—a potential therapeutic target. Molecular Carcinogenesis, 55:335-345.
  5. Luo H, Zuo G, Xiong G, et al. (2016) Porous nanoplate-like hydroxyapatite–sodium alginate nanocomposite scaffolds for potential bone tissue engineering. Materials Technology Advanced Performance Materials, 2016:1-7.
  6. Meng XM, Chung AC, Lan HY. (2013) Role of the TGF-beta/BMP-7/Smad pathways in renal diseases. Clinical Science, 124:243-254.
  7. Nakashima K, Xin Z, Kunkel G, et al. (2002) The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation. Cell, 108:17-29.
  8. Ozdemir MT, Kir MÇ. (2011). Repair of long bone defects with demine-ralized bone matrix and autogenous bone composite. Orthop. 45: 226-230.
  9. Suqiang M, Jianqiang P, Zhongtan L, et al. (2012) Osteogenesis growth peptide chitosan - sodium alginate microspheres preparation and in vitro testing. Chinese Journal of Tissue Engineering Research, 16:4663-4666.
  10. Scarfì S. (2016). Use of bone morphogenetic proteins in mesenchymal stemcell stimulation of cartilage and bone repair. World Journal of Stem Cells, 8:1-12.
  11. Weiskirchen R, Meurer SK. (2013). BMP-7 counteracting TGF-beta1 activities in organ fibrosis. Frontiers in Bioscience (Landmark Edition), 18:1407-1434.

Global Footprints